Sales of Philadelphia-born gene therapy product hit $27M during first year
February 19, 2019 at 10:07 AM EST
Spark Therapeutics shipped 75 vials of Luxturna, a treatment for a rare eye disorder that leads to blindness, to treatment centers around the country last year.
